Missing Links?: 1093 Citation Matrix | Graphs | Glossary HistCite Guide About |
Nodes: 10146,
Authors: 16970,
Journals: 1137,
Outer References: 208320,
Words: 13772
Collection span: 1949 - 2005
View: Overview. Sorted by journal name.
Page 7 of 102: [ 1 2 3 4 5 6 7 8 9 10 ] 11 21 31 41 51 61 71 81 91 | 101
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
---|---|---|---|---|---|
601 | 14 | 127 | 752 1964 ANNUAL REVIEW OF NUCLEAR SCIENCE 14: 347-& WHITMORE GF; TILL JE QUANTITATION OF CELLULAR RADIOBIOLOGICAL RESPONSES | 13 | 160 |
602 | 16 | 279 | 1341 1967 ANNUAL REVIEW OF NUCLEAR SCIENCE 17: 469-& GINOZA W EFFECTS OF IONIZING RADIATION ON NUCLEIC ACIDS OF BACTERIOPHAGES AND BACTERIAL CELLS | 1 | 15 |
603 | 5 | 218 | 1793 1969 ANNUAL REVIEW OF NUCLEAR SCIENCE 19: 139-& BRIDGES BA MECHANISMS OF RADIATION MUTAGENESIS IN CELLULAR AND SUBCELLULAR SYSTEMS | 5 | 53 |
604 | 12 | 199 | 937 1965 ANNUAL REVIEW OF PHARMACOLOGY 5: 53-& BURCHALL JJ; FERONE R; HITCHING.GH ANTIBACTERIAL CHEMOTHERAPY | 2 | 5 |
605 | 11 | 178 | 1129 1966 ANNUAL REVIEW OF PHARMACOLOGY 6: 231-& EGGERS HJ; TAMM I ANTIVIRAL CHEMOTHERAPY | 4 | 25 |
606 | 19 | 244 | 1342 1967 ANNUAL REVIEW OF PHARMACOLOGY 7: 101-& HEIDELBERGER C CANCER CHEMOTHERAPY WITH PURINE AND PYRIMIDINE ANALOGUES | 4 | 59 |
607 | 16 | 106 | 1794 1969 ANNUAL REVIEW OF PHARMACOLOGY 9: 393-& SCHINDLE.R USE OF CELL CULTURE IN PHARMACOLOGY | 0 | 12 |
608 | 12 | 240 | 2069 1970 ANNUAL REVIEW OF PHARMACOLOGY 10: 143-& GOZ B; PRUSOFF WH PHARMACOLOGY OF VIRUSES | 10 | 44 |
609 | 15 | 192 | 2414 1971 ANNUAL REVIEW OF PHARMACOLOGY 11: 369-& YOUNG CW; BURCHENA.JH CANCER CHEMOTHERAPY | 0 | 11 |
610 | 19 | 178 | 2733 1972 ANNUAL REVIEW OF PHARMACOLOGY 12: 35-& HASH JH ANTIBIOTIC MECHANISMS | 0 | 21 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
611 | 27 | 769 | 596 1963 ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY 3: 357-& KARNOFSKY DA; CLARKSON BD CELLULAR EFFECTS OF ANTICANCER DRUGS | 11 | 81 |
612 | 7 | 193 | 3488 1974 ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY 14: 157-183 CARTER SK; SLAVIK M CHEMOTHERAPY OF CANCER | 1 | 29 |
613 | 4 | 130 | 8256 1990 ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY 30: 149-168 MASON JM; LANGENBACH R; SHELBY MD; ZEIGER E; TENNANT RW ABILITY OF SHORT-TERM TESTS TO PREDICT CARCINOGENESIS IN RODENTS | 0 | 13 |
614 | 13 | 204 | 2415 1971 ANNUAL REVIEW OF PHYSICAL CHEMISTRY 22: 25-& CANTOR CR; KATZ L NUCLEIC ACIDS | 0 | 3 |
615 | 1 | 204 | 79 1954 ANNUAL REVIEW OF PHYSIOLOGY 16: 81-102 HOROWITZ NH; OWEN RD PHYSIOLOGICAL ASPECTS OF GENETICS | 1 | 12 |
616 | 3 | 196 | 938 1965 ANNUAL REVIEW OF PHYTOPATHOLOGY 3: 231-& STOLP H; STARR MP; BAIGENT NL PROBLEMS IN SPECIATION OF PHYTOPATHOGENIC PSEUDOMONADS AND XANTHOMONADS | 2 | 35 |
617 | 4 | 109 | 1343 1967 ANNUAL REVIEW OF PHYTOPATHOLOGY 5: 109-& GEORGOPO.SG; ZARACOVI.C TOLERANCE OF FUNGI TO ORGANIC FUNGICIDES | 0 | 46 |
618 | 3 | 67 | 1527 1968 ANNUAL REVIEW OF PHYTOPATHOLOGY 6: 63-& DELEY J DNA BASE COMPOSITION AND HYBRIDIZATION IN TAXONOMY OF PHYTOPATHOGENIC BACTERIA | 0 | 38 |
619 | 6 | 101 | 7187 1985 ANNUAL REVIEW OF PHYTOPATHOLOGY 23: 297-320 MILLS D TRANSPOSON MUTAGENESIS AND ITS POTENTIAL FOR STUDYING VIRULENCE GENES IN PLANT-PATHOGENS | 0 | 22 |
620 | 5 | 193 | 1795 1969 ANNUAL REVIEW OF PLANT PHYSIOLOGY 20: 63-& GLASZIOU KT CONTROL OF ENZYME FORMATION AND INACTIVATION IN PLANTS | 2 | 89 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
621 | 3 | 110 | 341 1961 ANNUAL REVIEW OF PLANT PHYSIOLOGY AND PLANT MOLECULAR BIOLOGY 12: 327-& TAYLOR JH GROWTH AND DEVELOPMENT - PHYSIOLOGY OF MITOSIS AND MEIOSIS | 1 | 8 |
622 | 4 | 21 | 7857 1988 ANTI-CANCER DRUG DESIGN 3 (1): 67-76 FERGUSON LR; PALMER BD; DENNY WA MICROBIAL MUTAGENICITY OF CHLORAMBUCIL, ITS HALF-MUSTARD AND MITOMYCIN-C - A MODIFIED SCREENING STRATEGY FOR GENETIC TOXICOLOGY OF BIS-ALKYLATING ANTI-TUMOR DRUGS | 1 | 16 |
623 | 3 | 30 | 8064 1989 ANTI-CANCER DRUG DESIGN 3 (4): 271-282 ELLIOTT JA; WILSON WD; SHEA RG; HARTLEY JA; RESZKA K; et al. INTERACTION OF BISANTRENE ANTI-CANCER AGENTS WITH DNA - FOOTPRINTING, STRUCTURAL REQUIREMENTS FOR DNA UNWINDING, KINETICS AND MECHANISM OF BINDING AND CORRELATION OF STRUCTURAL AND KINETIC-PARAMETERS WITH ANTI-CANCER ACTIVITY | 0 | 5 |
624 | 6 | 60 | 8458 1991 ANTI-CANCER DRUG DESIGN 6 (6): 569-584 HELENE C THE ANTI-GENE STRATEGY - CONTROL OF GENE-EXPRESSION BY TRIPLEX-FORMING-OLIGONUCLEOTIDES | 4 | 259 |
625 | 3 | 31 | 9316 1996 ANTI-CANCER DRUG DESIGN 11 (8): 581-596 Gupta R; Liu JX; Xie GJ; Lown JW Novel DNA-directed alkylating agents consisting of naphthalimide, nitrogen mustard and lexitropsin moieties: Synthesis, DNA sequence specificity and biological evaluation | 0 | 6 |
626 | 17 | 84 | 9561 1998 ANTI-CANCER DRUG DESIGN 13 (6): 593-609 Jaffar M; Naylor MA; Robertson N; Stratford IJ Targeting hypoxia with a new generation of indolequinones | 0 | 24 |
627 | 2 | 35 | 8637 1992 ANTI-CANCER DRUGS 3 (1): 33-38 KUSUMOTO H; MAEHARA Y; YOSHIDA M; TAKAHASHI I; ANAI H; et al. RELATIONSHIP BETWEEN TUMOR HISTOPATHOLOGY AND INVITRO SENSITIVITY TO ANTITUMOR DRUGS IN GASTRIC-CANCER | 0 | 8 |
628 | 0 | 0 | 1344 1967 ANTIBIOTICS 1: 211-245 SZYBALSKI W; IYER VN The Mitomycins and Porfiromycins. (In: D. Gottlieb and P. D. Shaw (Eds.), Antibiotics, Vol. 1, Mechanism of Action) | 174 | 174 |
629 | 1 | 16 | 45 1953 ANTIBIOTICS AND CHEMOTHERAPY 3 (6): 581-586 FUSILLO MH; NOYES HE; PULASKI EJ; TOM JYS ANTIMICROBIAL SPECTRUM AND CROSS RESISTANCE STUDIES OF ERYTHROMYCIN AND CARBOMYCIN | 6 | 23 |
630 | 1 | 13 | 46 1953 ANTIBIOTICS AND CHEMOTHERAPY 3 (9): 915-919 SZYBALSKI W NATURAL AND ARTIFICIAL PENICILLIN RESISTANCE IN STAPHYLOCOCCUS (MICROCOCCUS-PYOGENES VAR AUREUS) | 38 | 38 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
631 | 3 | 25 | 47 1953 ANTIBIOTICS AND CHEMOTHERAPY 3 (11): 1095-1103 SZYBALSKI W GENETIC STUDIES ON MICROBIAL CROSS RESISTANCE TO TOXIC AGENTS .2. CROSS RESISTANCE OF MICROCOCCUS-PYOGENES VAR AUREUS TO 34 ANTIMICROBIAL DRUGS | 20 | 20 |
632 | 1 | 4 | 48 1953 ANTIBIOTICS AND CHEMOTHERAPY 3 (12): 1243-1246 VANDIJCK PJ; VANDEVOORDE HP; DESOMER P PRELIMINARY NOTES ON GRISEOMYCIN, A NEW ANTIBIOTIC | 0 | 9 |
633 | 1 | 9 | 80 1954 ANTIBIOTICS AND CHEMOTHERAPY 4 (3): 300-303 DENUNZIO JC; BOWMAN FW; KIRSHBAUM A THE BIOLOGIC ASSAY OF NEOMYCIN IN COMBINATION WITH DIHYDROSTREPTOMYCIN, USING A TEST ORGANISM MADE RESISTANT TO DIHYDROSTREPTOMYCIN | 0 | 2 |
634 | 1 | 12 | 342 1961 ANTIBIOTICS AND CHEMOTHERAPY 11 (3): 196-& DOBRZANS.W CONVERSION TO STREPTOMYCIN RESISTANCE (AKIBAS PHENOMENON) IN A PRESUMABLY STATIONARY POPULATION OF STAPHYLOCOCCUS AUREUS | 0 | 0 |
635 | 2 | 8 | 343 1961 ANTIBIOTICS AND CHEMOTHERAPY 11 (12): 797-& RAGNI G; BOROWSKI E; SCHAFFNER CP; SZYBALSKI W N-ACETYLCANDIDIN, A WATER-SOLUBLE POLYENE ANTIBIOTIC FOR FUNGAL PROPHYLAXIS AND DECONTAMINATION OF TISSUE CULTURES | 6 | 6 |
636 | 3 | 272 | 344 1961 ANTIBIOTIKI 6 (5): 453-& SAZYKIN YO MECHANISM OF ACTIVITY OF ANTIBIOTICS ON METABOLISM OF MICROORGANISMS | 0 | 2 |
637 | 1 | 18 | 345 1961 ANTIBIOTIKI 6 (7): 643-& GAUZE GF; KOCHETKOV GV VULNERABILITY OF NUCLEIC ACIDS IN MUTANT STAPHYLOCOCCI USED IN SCREENING FOR ANTICANCER PRODUCTS | 0 | 0 |
638 | 2 | 12 | 2416 1971 ANTIBIOTIKI 16 (3): 218-& KOLOBOV AV; ABIDOVA M; GUBERNIE.MA EFFECT OF MITOMYCIN-C ON POLYNUCLEOTIDEPHOSPHORYLASE ACTIVITY IN EXPERIMENTS WITH MICROORGANISMS AND INTACT CELLS | 0 | 0 |
639 | 2 | 7 | 2417 1971 ANTIBIOTIKI 16 (5): 400-& ESELEVIC.MM; SAZYKIN YO; TORBOCHK.LI STUDIES ON MECHANISM OF ACTION OF VARIAMYCIN | 0 | 2 |
640 | 3 | 13 | 2418 1971 ANTIBIOTIKI 16 (6): 487-& DUDNIK YV; NETYKSA EM; VARIK OY INCREASED ANTIBACTERIAL EFFECT OF BRUNEOMYCIN AND SIBIROMYCIN IN CULTURES WITH IMPAIRED REPERATION OF DNA | 1 | 3 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
641 | 3 | 103 | 2734 1972 ANTIBIOTIKI 17 (2): 172-& KOCHETKO.GV MICROORGANISMS AS TEST-OBJECTS IN SCREENING PROGRAMS OF ANTITUMOR ANTIBIOTICS | 0 | 0 |
642 | 4 | 10 | 3112 1973 ANTIBIOTIKI 18 (3): 223-227 TOLKACHE.EN; TIMOFEEV.EA SENSITIVITY OF HUMAN TUMOR-CELLS IN CULTURE TO MITHOMYCIN C AND THIOPHOSPHAMIDE | 0 | 1 |
643 | 1 | 16 | 3113 1973 ANTIBIOTIKI 18 (6): 566-568 KULYASH YV; SHENDERO.BA; FILIMONO.LS STUDY OF TEMPERATURE EFFECT ON RESISTANCE OF STAPHYLOCOCCUS-AUREUS TO SOME DRUGS AND ON ACTIVITY OF ENZYMES OF TERMINAL STAGE OF ELECTRON-TRANSPORT CHAIN | 0 | 0 |
644 | 3 | 25 | 3114 1973 ANTIBIOTIKI 18 (9): 802-807 MAKAROVS.VV; PIRTSKHA.DS; SPITKOVS.DM; FEDOROV SN CONDENSING EFFECT OF ACTINOMYCIN ON INTERACTION WITH NUCLEAR CHROMATIN OF SOMATIC-CELLS | 0 | 2 |
645 | 2 | 15 | 3115 1973 ANTIBIOTIKI 18 (11): 968-973 DUDNIK YV; GAUZE GG; KARPOV VL; KOZMYAN LI; PADRON E INTERACTION IN-VITRO OF BRUNEOMYCIN (STREPTONIGRIN) WITH DNA | 1 | 8 |
646 | 1 | 23 | 3489 1974 ANTIBIOTIKI 19 (1): 74-78 MIRZAEVA MA DEVELOPMENT OF RESISTANCE TO SOME ANTIBIOTICS IN BRUCELLA ON THEIR PASSAGES TO MEDIA WITH ANTIBIOTICS | 0 | 0 |
647 | 1 | 10 | 3490 1974 ANTIBIOTIKI 19 (8): 729-732 ZHELEVA M; GENOVA YG; URUMOV A SOME CHANGES IN ANTIGENIC COMPLEX OF BACILLUS ANTHRACIS UNDER STREPTOMYCIN EFFECT | 0 | 0 |
648 | 1 | 14 | 3867 1975 ANTIBIOTIKI 20 (6): 488-494 LETYAGIN KP; BARTOSHEVICH YE; TETERYATNIK AF VARIATION OF ACT-CIRCULATUS VAR MONOMYCINI INDUCED BY N-5-NITROZO-N-METHYLBIURET | 0 | 0 |
649 | 1 | 12 | 5237 1979 ANTIBIOTIKI 24 (7): 498-502 NEMCHENKO VV; DOMBROVSKY AM CHANGES IN BIOLOGICAL PROPERTIES OF SALMONELLA DURING DEVELOPMENT OF RESISTANCE TO CHLORAMPHENICOL | 0 | 0 |
650 | 1 | 9 | 5913 1981 ANTIBIOTIKI 26 (5): 345-349 TEREKHOVA LP; GALATENKO OA; PREOBRAZHENSKAYA TA ANTIBIOTIC-SENSITIVITY OF ACTINOMYCETES BELONGING TO ACTINOMADURA | 0 | 0 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
651 | 8 | 70 | 6257 1982 ANTIBIOTIKI 27 (3): 221-234 KRYLOV AS MOLECULAR-MODELS OF COMPLEXES OF DNA AND ANTI-TUMOR ANTIBIOTICS, SPECIFIC FOR DEFINITE DNA BASES | 0 | 0 |
652 | 5 | 107 | 6577 1983 ANTIBIOTIKI 28 (6): 462-471 ZHUKOVA RA; LAVRENTYEVA GI USE OF ANTIBIOTICS IN THE SELECTION OF MICROORGANISMS PRODUCING BIOLOGICALLY-ACTIVE SUBSTANCES | 0 | 0 |
653 | 2 | 5 | 6907 1984 ANTIBIOTIKI 29 (5): 391-393 SMOLYANSKAYA AZ; SPASIBINA TV PHARMACOKINETICS OF MITOMYCIN-C IN ONCOLOGICAL PATIENTS SUBJECTED TO PROLONGED ADMINISTRATION OF THE DRUG | 0 | 0 |
654 | 1 | 37 | 6908 1984 ANTIBIOTIKI 29 (7): 519-527 KRIVOSHEIN YS; SKURATOVICH AA; TYSHKEVICH LV; RUDKO AP STUDY ON MUTAGENIC AND CARCINOGENIC EFFECTS OF ANTIMICROBIAL SURFACE-ACTIVE SUBSTANCES | 0 | 0 |
655 | 4 | 99 | 8459 1991 ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS 4 (3): 245-272 BUCHSBAUM DJ; LAWRENCE TS TUMOR-THERAPY WITH RADIOLABELED MONOCLONAL-ANTIBODIES | 0 | 33 |
656 | 34 | 148 | 7430 1986 ANTICANCER RESEARCH 6 (4): 605-619 DRIEBERGEN RJ; HOLTHUIS JJM; HULSHOFF A; POSTMAKELDER SJ; VERBOOM W; et al. ELECTROCHEMISTRY OF POTENTIAL BIOREDUCTIVE ALKYLATING QUINONES - ITS USE IN THE DEVELOPMENT OF NEW AZIRIDINYLQUINONES | 1 | 21 |
657 | 5 | 208 | 7653 1987 ANTICANCER RESEARCH 7 (6): 1085-1104 STUBBLEFIELD E; SANFORD J A GENERAL SURVEY OF GENETICS AND CANCER | 1 | 10 |
658 | 3 | 23 | 7654 1987 ANTICANCER RESEARCH 7 (6): 1245-1250 HILL M; HILLOVA J; BRADA Z; MARIAGESAMSON R MUTAGENICITY OF METHIONINE OR ITS METABOLIC PRODUCTS IN RSV-TRANSFORMED CHINESE-HAMSTER FIBROBLASTS | 0 | 0 |
659 | 12 | 29 | 7858 1988 ANTICANCER RESEARCH 8 (3): 471-474 CHEITLIN RA; BODELL WJ APPLICATION OF AN ELISA PROCEDURE FOR THE QUANTITATION OF BROMODEOXYURIDINE INCORPORATED INTO CELLULAR DNA | 0 | 5 |
660 | 3 | 20 | 8460 1991 ANTICANCER RESEARCH 11 (3): 1301-1304 YUSA K; SATO W; YAMAZAKI A; TSUKAHARA S; TSURUO T CROSS-RESISTANCE OF HUMAN MULTIDRUG-RESISTANT CELLS TO MITOMYCIN-C | 0 | 5 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
661 | 3 | 9 | 8817 1993 ANTICANCER RESEARCH 13 (1): 17-20 WILSON WW; MEBANE EW; HOFFMAN RM CREATION OF ULTRA-RARE RESTRICTION SITES IN INTACT EUKARYOTIC CHROMOSOMES MEDIATED BY BACTERIAL METHYLASES - AN APPROACH TO SEQUENCING AND ANALYZING TUMOR AND NORMAL GENOMES | 0 | 0 |
662 | 10 | 32 | 8818 1993 ANTICANCER RESEARCH 13 (3): 655-660 OHARA C; BEPPU T; YAMAGUCHI Y; MASUDA Y; FUKUSHIMA S; et al. EVALUATION OF A NEW LIPOPHILIC PRODRUG 3',5'-DIOCTANOYL-5-BROMODEOXYURIDINE (BRDU-C8) SUSPENDED IN LIPIODOL AS A RADIOSENSITIZER FOR THE TREATMENT OF AH136B TUMOR | 0 | 0 |
663 | 3 | 43 | 8999 1994 ANTICANCER RESEARCH 14 (5A): 1727-1733 JESUDASAN RA; SLOVAK ML; SEN S; SRIVATSAN ES REARRANGEMENT OF CHROMOSOME BAND 11Q13 IN HELA-CELLS | 0 | 13 |
664 | 6 | 101 | 9456 1997 ANTICANCER RESEARCH 17 (1A): 189-196 Bodey B; Bodey B; Groger AM; Siegel SE; Kaiser HE Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors | 0 | 14 |
665 | 6 | 17 | 2735 1972 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 1 (1): 73-& MERCADO CM; TOMASZ M INHIBITORY EFFECTS OF MITOMYCIN-RELATED COMPOUNDS LACKING C1-C2 AZIRIDINE RING | 14 | 15 |
666 | 6 | 33 | 2736 1972 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 22 (5): 373-& ROSENKRANZ HS; ROSENKRA.S SILVER SULFADIAZINE - INTERACTION WITH ISOLATED DEOXYRIBONUCLEIC ACID | 0 | 0 |
667 | 2 | 22 | 3116 1973 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 3 (6): 649-656 BLOCK ER; JENNINGS AE; BENNETT JE 5-FLUOROCYTOSINE RESISTANCE IN CRYPTOCOCCUS-NEOFORMANS | 1 | 56 |
668 | 7 | 41 | 3117 1973 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 3 (6): 670-676 PINNEY RJ; SMITH JT CURING OF AN R-FACTOR FROM ESCHERICHIA-COLI BY TRIMETHOPRIM | 3 | 13 |
669 | 1 | 16 | 3118 1973 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 4 (3): 248-253 COLE MA; ELKAN GH TRANSMISSIBLE RESISTANCE TO PENICILLIN-G, NEOMYCIN, AND CHLORAMPHENICOL IN RHIZOBIUM-JAPONICUM | 0 | 142 |
670 | 1 | 10 | 3119 1973 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 4 (4): 495-496 MAJESKI JA; COLE BT IMMUNOSUPPRESSIVE EFFECT OF 6-MERCAPTOPURINE AND MITOMYCIN-C | 1 | 1 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
671 | 2 | 18 | 3491 1974 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 6 (6): 848-852 ISAACSON RE; KONISKY J STUDIES ON REGULATION OF COLICIN IB SYNTHESIS - REPLICATION OF COL IB-P9 PLASMID DURING COLICIN INDUCTION | 0 | 3 |
672 | 2 | 14 | 3868 1975 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 7 (5): 507-516 DREWS J; GEORGOPOULOS A; LABER G; SCHUTZE E; UNGER J ANTIMICROBIAL ACTIVITIES OF 81.723 HFU, A NEW PLEUROMUTILIN DERIVATIVE | 0 | 60 |
673 | 1 | 17 | 4215 1976 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 9 (1): 36-41 CHABBERT YA; SCAVIZZI MR CHELOCARDIN-INDUCIBLE RESISTANCE IN ESCHERICHIA-COLI BEARING R-PLASMIDS | 1 | 22 |
674 | 4 | 20 | 4216 1976 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 9 (6): 928-938 BRYAN LE; VANDENELZEN HM STREPTOMYCIN ACCUMULATION IN SUSCEPTIBLE AND RESISTANT STRAINS OF ESCHERICHIA-COLI AND PSEUDOMONAS-AERUGINOSA | 0 | 123 |
675 | 4 | 29 | 4567 1977 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 12 (1): 84-92 GENTHER CS; SCHOENY RS; LOPER JC; SMITH CC MUTAGENIC STUDIES OF FOLIC-ACID ANTAGONISTS | 2 | 15 |
676 | 1 | 34 | 4568 1977 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 12 (3): 383-389 SINHA RP ACRIFLAVINE-RESISTANT MUTANT OF STREPTOCOCCUS-CREMORIS | 0 | 2 |
677 | 8 | 38 | 4915 1978 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 13 (1): 19-24 LARUSSO NF; TOMASZ M; KAPLAN D; MULLER M ABSENCE OF STRAND BREAKS IN DEOXYRIBONUCLEIC-ACID TREATED WITH METRONIDAZOLE | 0 | 18 |
678 | 9 | 51 | 4916 1978 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 13 (5): 770-783 SUTER W; ROSSELET A; KNUSEL F MODE OF ACTION OF QUINDOXIN AND SUBSTITUTED QUINOXALINE-DI-N-OXIDES ON ESCHERICHIA-COLI | 0 | 46 |
679 | 0 | 17 | 4917 1978 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 14 (1): 51-59 NKANGA EJ; HAGEDORN C DETECTION OF ANTIBIOTIC-PRODUCING STREPTOMYCES INHABITING FOREST SOILS | 0 | 0 |
680 | 1 | 29 | 4918 1978 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 14 (5): 771-779 MIHELC VA; DUNCAN CL; CHAMBLISS GH CHARACTERIZATION OF A BACTERIOCINOGENIC PLASMID IN CLOSTRIDIUM-PERFRINGENS CW55 | 0 | 17 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
681 | 2 | 31 | 5238 1979 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 15 (5): 738-746 VEZINA C; BOLDUC C; KUDELSKI A; AUDET P BIOSYNTHESIS OF KITASAMYCIN (LEUCOMYCIN) BY LEUCINE ANALOG-RESISTANT MUTANTS OF STREPTOMYCES-KITASATOENSIS | 0 | 9 |
682 | 2 | 35 | 6258 1982 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 22 (5): 791-799 MCMURRY LM; CULLINANE JC; LEVY SB TRANSPORT OF THE LIPOPHILIC ANALOG MINOCYCLINE DIFFERS FROM THAT OF TETRACYCLINE IN SUSCEPTIBLE AND RESISTANT ESCHERICHIA-COLI STRAINS | 0 | 30 |
683 | 1 | 21 | 6578 1983 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 24 (2): 194-200 WHITELEY M; TAYLOR DE IDENTIFICATION OF DNA HOMOLOGIES AMONG H-INCOMPATIBILITY GROUP PLASMIDS BY RESTRICTION ENZYME DIGESTION AND SOUTHERN TRANSFER HYBRIDIZATION | 0 | 30 |
684 | 2 | 19 | 6579 1983 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 24 (6): 930-935 TAYLOR DE; GARNER RS; ALLAN BJ CHARACTERIZATION OF TETRACYCLINE RESISTANCE PLASMIDS FROM CAMPYLOBACTER-JEJUNI AND CAMPYLOBACTER-COLI | 1 | 62 |
685 | 2 | 31 | 6909 1984 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 25 (6): 676-682 CATLIN BW PROBENECID - ANTIBACTERIAL ACTION AGAINST NEISSERIA-GONORRHOEAE AND INTERACTION WITH BENZYLPENICILLIN | 0 | 7 |
686 | 2 | 24 | 7431 1986 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 29 (2): 320-324 SAMUEL J; GILL MJ; IWASHINA T; TOVELL DR; TYRRELL DL; et al. PHARMACOKINETICS AND METABOLISM OF E-5-(2-[I-131]IODOVINYL)-2'- DEOXYURIDINE IN DOGS | 1 | 27 |
687 | 1 | 40 | 7655 1987 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 31 (4): 523-526 SCAVIZZI MR; ALONSO JM; PHILIPPON AM; JUPEAUVESSIERES AM; GUIYOULE A FAILURE OF NEWER BETA-LACTAM ANTIBIOTICS FOR MURINE YERSINIA-ENTEROCOLITICA INFECTION | 2 | 21 |
688 | 1 | 30 | 7656 1987 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 31 (10): 1589-1595 MARCHOU B; BELLIDO F; CHARNAS R; LUCAIN C; PECHERE JC CONTRIBUTION OF BETA-LACTAMASE HYDROLYSIS AND OUTER-MEMBRANE PERMEABILITY TO CEFTRIAXONE RESISTANCE IN ENTEROBACTER-CLOACAE | 2 | 49 |
689 | 3 | 18 | 7657 1987 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 31 (11): 1803-1808 MICHEAHAMZEHPOUR M; AUCKENTHALER R; REGAMEY P; PECHERE JC RESISTANCE OCCURRING AFTER FLUOROQUINOLONE THERAPY OF EXPERIMENTAL PSEUDOMONAS-AERUGINOSA PERITONITIS | 0 | 78 |
690 | 1 | 16 | 7859 1988 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 32 (1): 24-26 LIEBOWITZ LD; SAUNDERS J; CHALKLEY LJ; KOORNHOF HJ INVITRO SELECTION OF BACTERIA RESISTANT TO LY146032, A NEW CYCLIC LIPOPEPTIDE | 0 | 8 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
691 | 1 | 12 | 8065 1989 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 33 (8): 1184-1187 KAATZ GW; SEO SM; BARRIERE SL; ALBRECHT LM; RYBAK MJ CIPROFLOXACIN AND RIFAMPIN, ALONE AND IN COMBINATION, FOR THERAPY OF EXPERIMENTAL STAPHYLOCOCCUS-AUREUS ENDOCARDITIS | 0 | 49 |
692 | 1 | 13 | 8257 1990 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 34 (7): 1376-1380 KAATZ GW; SEO SM WIN-57273, A NEW FLUOROQUINOLONE WITH ENHANCED INVITRO ACTIVITY VERSUS GRAM-POSITIVE PATHOGENS | 0 | 18 |
693 | 1 | 21 | 8258 1990 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 34 (11): 2273-2276 NESIN M; SVEC P; LUPSKI JR; GODSON GN; KREISWIRTH B; et al. CLONING AND NUCLEOTIDE-SEQUENCE OF A CHROMOSOMALLY ENCODED TETRACYCLINE RESISTANCE DETERMINANT, TETA(M), FROM A PATHOGENIC, METHICILLIN-RESISTANT STRAIN OF STAPHYLOCOCCUS-AUREUS | 0 | 39 |
694 | 2 | 45 | 8461 1991 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 35 (9): 1785-1790 LEMAITRE BC; MAZIGH DA; SCAVIZZI MR FAILURE OF BETA-LACTAM ANTIBIOTICS AND MARKED EFFICACY OF FLUOROQUINOLONES IN TREATMENT OF MURINE YERSINIA-PSEUDOTUBERCULOSIS INFECTION | 1 | 10 |
695 | 1 | 16 | 8638 1992 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 36 (6): 1192-1197 KAATZ GW; SEO SM; LAMP KC; BAILEY EM; RYBAK MJ CI-960, A NEW FLUOROQUINOLONE, FOR THERAPY OF EXPERIMENTAL CIPROFLOXACIN-SUSCEPTIBLE AND -RESISTANT STAPHYLOCOCCUS-AUREUS ENDOCARDITIS | 0 | 15 |
696 | 1 | 30 | 8639 1992 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 36 (7): 1441-1446 CONDRA JH; EMINI EA; GOTLIB L; GRAHAM DJ; SCHLABACH AJ; et al. IDENTIFICATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE RESIDUES THAT CONTRIBUTE TO THE ACTIVITY OF DIVERSE NONNUCLEOSIDE INHIBITORS | 0 | 74 |
697 | 1 | 38 | 9155 1995 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 39 (9): 2019-2022 CHARVALOS E; TSELENTIS Y; HAMZEHPOUR MM; KOHLER T; PECHERE JC EVIDENCE FOR AN EFFLUX PUMP IN MULTIDRUG-RESISTANT CAMPYLOBACTER-JEJUNI | 0 | 49 |
698 | 1 | 26 | 9156 1995 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 39 (11): 2392-2396 HAMZEHPOUR MM; PECHERE JC; PLESIAT P; KOHLER T OPRK AND OPRM DEFINE 2 GENETICALLY DISTINCT MULTIDRUG EFFLUX SYSTEMS IN PSEUDOMONAS-AERUGINOSA | 1 | 17 |
699 | 3 | 27 | 9317 1996 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 40 (2): 325-330 Fournier JL; Ramisse F; Jacolot AC; Szatanik M; Petitjean OJ; et al. Assessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infections | 0 | 7 |
700 | 1 | 51 | 9318 1996 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 40 (2): 342-348 MartinezMartinez L; HernandezAlles S; Alberti S; Tomas JM; Benedi VJ; et al. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins | 2 | 89 |
Page 7 of 102: [ 1 2 3 4 5 6 7 8 9 10 ] 11 21 31 41 51 61 71 81 91 | 101
Generated by:
HistCite 2005.08.29